Market Overview According to a new report published by Reports Monitor titled, “Lichen Sclerosus Market by Treatment Form, Mode of Administration and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the lichen sclerosus market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025.
Lichen Sclerosus is chronic skin disease that creates patchy, white skin that is thinner than normal. The condition mainly affects skin in the genital and anal region. It is most commonly observed on the vulvas of the women. Symptoms include smooth white spots, severe itching, discomfort and painful sexual intercourse. In severe cases of lichen sclerosus it can turn into ulcerated lesions or open wound. Factor responsible for causing lichen sclerosus is still unknown but there are other possibilities that include hormonal imbalance and hyper immunity reaction or inflammation of the region.
Worldwide rising prevalence of skin diseases and highly growing number of immune system disorder drives the lichen sclerosus market. Moreover, females subjected to hormonal imbalance especially during menopause, tend to develop condition like lichen sclerosus boosts the market growth. Besides, increased exposure and sensitivity towards pathogenic organism is expected to fuel the growth. However, less awareness amidst populace and unavailability of exact cure for the treatment impedes the growth of the market. North America lichen sclerosus market is affected owing to well-developed healthcare infrastructure, large population affected with the skin diseases, demand for advanced treatment option and high expenditure on healthcare facilities.
The global lichen sclerosus market is segmented onto the basis of treatment form, mode of administration, distribution channel and region. Based on, treatment form the market is divided into creams, solutions and tablets. Depending upon mode of administration the market is separated into topical, oral, injection and others. According to distribution channel the market segregated into hospital pharmacies, clinics, online, pharmacies, retail pharmacies, drug stores and others.
Competitive Snapshot Players dominating the market include AstraZeneca plc. GlaxoSmithKline plc., Merck & Co., Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Novartis AG, Zylera Pharmaceuticals, Sanofi, Valeant Pharmaceuticals and Pfizer Inc.
About Garner Insights:
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.